Back to Home
Exin Therapeutics news
Exin Therapeutics appears in 1 story we have published in November 2026, mostly in our AI coverage.
Latest development
AI agent autonomously performs gene therapy surgery on live mouse using Claude Sonnet 5
An AI agent powered by Anthropic’s Claude Sonnet 5 model has autonomously selected a gene therapy, calculated surgical coordinates, and performed a brain injection procedure on a live mouse to reduce seizures. The experiment, conducted by Exin Therapeutics, demonstrates the potential of AI to execute complex medical tasks without human decision-making—though not without challenges.
2 November 2026
